InĆ­cio
Grupos
PƔginas
Marketplace
Ver mais
Grupos PƔginas Marketplace Eventos Blogs Funding Offers Courses
Entrar Cadastrar
Night Mode
š”š„š­šØš¦š¢š«š¢š¬ šƒš«š®š  šŒššš«š¤šžš­ š†š«šØš°š­š” Innovations in Rare Disease Biologics
The Ultomiris Drug Market is experiencing significant growth due to the increasing prevalence of rare autoimmune and hematologic disorders, rising awareness about complement-mediated diseases, and advancements in biologic therapies. Ultomiris (ravulizumab), a long-acting complement C5 inhibitor, has emerged as a breakthrough treatment for several life-threatening conditions, driving...
0 ComentĆ”rios Ā·0 Compartilhamentos Ā·309 VisualizaƧƵes Ā·0 Anterior
FaƧa o login para curtir, compartilhar e comentar!